Geno J. Merli, MD; Howard H. Weitz, MD
Disclosures: Geno J. Merli, MD, reports the following: Research grants/contracts: Bristol-Myers Squibb, Janssen, Portola; Consultancies: Bristol-Myers Squibb, Janssen. Howard H. Weitz, MD, reports that he has no financial relationships or interests to disclose.
Yehia Y. Mishriki
Lehigh Valley Health Network
May 20, 2017
Puzzling lipid panel
An excellent presentation, possibly your best yet.I suspect that no in depth comment was made regarding the lipid panel but it struck me as unusual as the numbers did not "add up" to what one would expected from the Friedewald formula. Would you recommend that the patient undergo a VAP lipid panel to determine subfractions of cholesterol not measured with the traditional lipid panel?
Howard Weitz, MD
Thomas Jefferson University
May 24, 2017
The case was a “real” patient and the lipid panel that was presented was his actual panel. We recommend that a traditional lipid panel be obtained in this patient. We do not believe that the additional information that the VAP panel provides any more information than the traditional panel in terms of an evidence and consensus based approach to cardiovascular risk reduction.
Merli GJ, Weitz HH. Annals Consult Guys - The Adult Survivor of Hodgkin Disease: Falling Through the Cracks. Ann Intern Med. 2017;166:CG1. doi: https://doi.org/10.7326/W17-0005
Download citation file:
Published: Ann Intern Med. 2017;166(10):CG1.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use